Noven Pharmaceuticals, Inc. engages in the research, development, manufacture, and marketing of advanced transdermal drug delivery technologies and prescription transdermal products primarily in the United States. Its principal products include prescription transdermal patches, which is used in menopausal hormone therapy. The company offers an estrogen patch for the treatment of menopausal symptoms marketed under the Vivelle name in the United States and Canada, and under Menorest name in Europe and other markets. Noven Pharmaceuticals also provides a second generation estrogen patch, the transdermal estrogen patch, under the Vivelle-Dot name in the United States and under Estradot name...